Blaes, J., Sahm, F., Wick, A., Deimling, A. v., Haberkorn, U., Abdollahi, A., . . . Lemke, D. (2018). Inhibition of CD95/CD95L (FAS/FASLG) signaling with APG101 prevents invasion and enhances radiation therapy for glioblastoma. Molecular cancer research, 16(5), . https://doi.org/10.1158/1541-7786.MCR-17-0563
Chicago-Zitierstil (17. Ausg.)Blaes, Jonas, et al. "Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma." Molecular Cancer Research 16, no. 5 (2018). https://doi.org/10.1158/1541-7786.MCR-17-0563.
MLA-Zitierstil (9. Ausg.)Blaes, Jonas, et al. "Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma." Molecular Cancer Research, vol. 16, no. 5, 2018, https://doi.org/10.1158/1541-7786.MCR-17-0563.